From: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate
Recurrence site
N
% of total recurrence
Liver
35
79.5
Any
14
31.8
Only
21
47.7
Intra-abdominal
13
29.5
8
18.2
Lung
1
2.3
Bone